Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by KayakerBCon Oct 09, 2020 12:26pm
166 Views
Post# 31695942

RE:RE:All This Whining and Complaining

RE:RE:All This Whining and ComplainingDeliver shareholder value and do the job effectively or get out.

By doing what?  Magic?  We have limited cash?  What do you expect someone else would do?  Do you want massive dilution at 38 cents?

How about **Promotion**!!  Do you want a promoter running this company instead of a scientist with extensive experience in "mergers and acquisitions, therapeutic product research and development, business development, licensing and commercialization"?  Any promoting beyond what they are doing now I'd consider a waste of time and money.  

People have no idea what DrDR is doing day-to-day to move this forward.  As usual, people assume THE WAIT means that she is doing nothing.  That's just a conversation in your head. This stock isn't moving up until we get more deals, milestone payments, and most importantly -- a clinical trial.  That's where DrDR is focused.

Are shareholders supposed to sit by idly, forever hoping that management will do their best and succeed ? .... DrDR, is it possible for you to make this investment any more boring ?  Your webinars are literal snorefests.  

No!  Let's take personal shots at DrDR!  That's a great idea!



Bullboard Posts